XBiotech Inc (XBIT)
8.955
-0.46
(-4.84%)
USD |
NASDAQ |
Apr 16, 16:00
8.955
0.00 (0.00%)
After-Hours: 17:05
XBiotech Shareholders Equity (Quarterly): 218.85M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 218.85M |
| September 30, 2023 | 222.66M |
| June 30, 2023 | 229.06M |
| March 31, 2023 | 236.90M |
| December 31, 2022 | 240.40M |
| September 30, 2022 | 244.81M |
| June 30, 2022 | 255.80M |
| March 31, 2022 | 265.56M |
| December 31, 2021 | 269.38M |
| September 30, 2021 | 274.16M |
| June 30, 2021 | 348.56M |
| March 31, 2021 | 352.10M |
| December 31, 2020 | 348.64M |
| September 30, 2020 | 346.14M |
| June 30, 2020 | 343.57M |
| March 31, 2020 | 347.08M |
| December 31, 2019 | 755.63M |
| September 30, 2019 | 64.62M |
| June 30, 2019 | 69.41M |
| March 31, 2019 | 36.98M |
| Date | Value |
|---|---|
| December 31, 2018 | 41.40M |
| September 30, 2018 | 46.94M |
| June 30, 2018 | 51.52M |
| March 31, 2018 | 56.41M |
| December 31, 2017 | 60.16M |
| September 30, 2017 | 67.15M |
| June 30, 2017 | 73.16M |
| March 31, 2017 | 82.27M |
| December 31, 2016 | 59.06M |
| September 30, 2016 | 71.63M |
| June 30, 2016 | 82.80M |
| March 31, 2016 | 94.68M |
| December 31, 2015 | 103.05M |
| September 30, 2015 | 114.08M |
| June 30, 2015 | 123.98M |
| March 31, 2015 | 54.86M |
| December 31, 2014 | 59.03M |
| September 30, 2014 | 17.22M |
| December 31, 2013 | 10.23M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
64.62M
Minimum
Sep 2019
755.63M
Maximum
Dec 2019
285.97M
Average
265.56M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 39.70M |
| Ampio Pharmaceuticals Inc | 3.36M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 226.62M |
| Total Liabilities (Quarterly) | 7.769M |